Signe Bergliot Nielsen

Enthusiastic researcher in Head & Neck Cancer of Unknown Primary. In the intersection between surgery and radiation oncology, on behalf of the DAHANCA group.

[Signe Bergliot Nielsen @SigneBergliot]

I am proud to announce, on behalf of the DAHANCA group, that our national phase IV study on cancer of unknown primary in the head and neck is out! 📣📣

We thoroughly evaluated the current Danish management strategy of this complicated disease.

https://t.co/dPhzLIPw6a

[Signe Bergliot Nielsen @SigneBergliot]

A pleasure for me to participate in #ECHNO2025 in Amsterdam, gathering experts in head and neck cancer. Thank you for interesting discussions after my talk in the DAHANCA session on TBM by TORS in HNSCCUP. Also, congratulations to @SomiahSiddiq for a brilliant review on the topic

[Signe Bergliot Nielsen @SigneBergliot]

@SixtenHarborg @AndersMlby @cancer_dk @LancetRH_Europe Congratulations on the great paper, Anders!

[Signe Bergliot Nielsen @SigneBergliot]

@claire_paters0n Dear Claire. Thank you for the question, which is highly relevant as these patients go through extensive work-up. The present study does not answer that question. Luckily, we adressed that in another study which is soon to be published. I will make a announcement when it's out.

[Signe Bergliot Nielsen @SigneBergliot]

Our national study presenting the largest cohort of patients with head and neck cancer of unknown primary (HNSCCUP) undergoing tongue base mucosectomy after guideline based work-up is now published! Please take a look.

https://t.co/6VsnLt10Rp

[Signe Bergliot Nielsen @SigneBergliot]

Welcoming everyone with an interest in head and neck cancer of unknown primary to participate in my PhD defence in Aarhus, on the 31st of May.

[Signe Bergliot Nielsen @SigneBergliot]

🗞️Publication alert! ✍️

I am happy to share that our dose plan study comparing protons vs. photons in the primary and recurrent setting of head and neck SCC of unknown primary is out.

https://t.co/J9U8gZPjeK

[Signe Bergliot Nielsen @SigneBergliot]

@oncaarhus @anne Amazing work, Anne-Mette! Looking forward to hear about your presentation!

[Signe Bergliot Nielsen @SigneBergliot]

@oncaarhus You look very determined, guys! Have a nice course!

[Signe Bergliot Nielsen @SigneBergliot]

@KristianQvist Pyh....jeg er virkelig glad for at der ikke skete jer noget! Det er SÅ utroligt farligt! "Kør bil, når du kører bil!" ☝️😳

[Signe Bergliot Nielsen @SigneBergliot]

@claire_paters0n @ESTRO_RT @oncaarhus Thank you! 🙏

[Signe Bergliot Nielsen @SigneBergliot]

Yesterday was a big! On behalf of the DAHANCA group, I had the great honor to present the results of our point of origin based pattern of failure study on IMRT treated patients with cancer of unknown primary in the head and neck (HNSCC CUP) at ESTRO
@ESTRO_RT @oncaarhus

[Signe Bergliot Nielsen @SigneBergliot]

@aallam_mo @ESTRO_RT @oncaarhus Exactly! And I feel that the more I dig into this area of ​​interest, the more exciting the mystery of the unknown becomes!

[Signe Bergliot Nielsen @SigneBergliot]

@VinPaleri @ESTRO_RT @oncaarhus Yet unpublished, but will be published soon. Data shows that the point of origins of the nodal failures in overall are lying within the high dose areas, i.e. by the bilateral elective neck approach we "hit the target". However, mucosal failures is another story...

[Signe Bergliot Nielsen @SigneBergliot]

@SomiahSiddiq @ESTRO_RT @oncaarhus Thank you Somiah!

[Signe Bergliot Nielsen @SigneBergliot]

@KrauseProf @ESTRO_RT @oncaarhus Thank you Professor Krause.

[Signe Bergliot Nielsen @SigneBergliot]

@duvvuri_md @ESTRO_RT @oncaarhus Will be published soon.

[Signe Bergliot Nielsen @SigneBergliot]

Thrilled by Trine Tramm's presentation on hos immunity and tumour microenvironment as a predictor of RT. Trine has excellent communication skills and her research is outstanding!
#ESTRO23

[Signe Bergliot Nielsen @SigneBergliot]

@oncaarhus @AUHdk Sharing our knowledge, is one of the most important weapons we have in the fight against cancer. ESTRO is the place where researchers meet and equip together. I'm proud to have been a part of this year's most powerful exchange of experiences!

[Department of Oncology, Aarhus University Hospital @oncaarhus]

#estro2022
#CancerResearch
@AUHdk